TIM
GILD icon

Thor Investment Management’s Gilead Sciences GILD Stock Holding History

Thor Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.9M Sell
22,956
-262
-1% -$34.5K 1.65% 18
2026
Q1 		$3.24M Sell
23,218
-28,851
-55% -$4.04M 1.72% 17
2025
Q4 		$6.39M Sell
52,069
-157
-0.3% -$19.1K 3.66% 5
2025
Q3 		$5.8M Sell
52,226
-214
-0.4% -$24.3K 3.49% 7
2025
Q2 		$5.81M Buy
52,440
+229
+0.4% +$24.4K 3.94% 5
2025
Q1 		$5.85M Sell
52,211
-204
-0.4% -$21.1K 4.29% 5
2024
Q4 		$4.84M Buy
52,415
+725
+1% +$65.3K 3.72% 7
2024
Q3 		$4.33M Buy
51,690
+1,767
+4% +$135K 3.16% 7
2024
Q2 		$3.43M Buy
49,923
+2,815
+6% +$188K 2.69% 10
2024
Q1 		$3.45M Buy
47,108
+1,702
+4% +$131K 2.73% 12
2023
Q4 		$3.68M Buy
+45,406
New +$3.53M 3.21% 10

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Thor Investment Management's GILD Position: Q2 2026 in Review

Thor Investment Management reduced its Gilead Sciences (GILD) stake by 1.1% in Q2 2026, selling an estimated $34.5K and leaving 22,956 shares worth $2.9M. The position accounts for 1.65% of the portfolio, ranked #18.

Thor Investment Management first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.39M in Q4 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Thor Investment Management held 22,956 shares of Gilead Sciences worth $2.9M as of Q2 2026.
  • Thor Investment Management sold 262 Gilead Sciences shares in Q2 2026, an estimated $34.5K.
  • Gilead Sciences made up 1.65% of Thor Investment Management's portfolio in Q2 2026, its #18 holding.
  • Thor Investment Management first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Thor Investment Management's Gilead Sciences position peaked at $6.39M in Q4 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Thor Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.